PURPOSE: To establish a multivariate normal tissue complication probability (NTCP) model for radiation-induced asymptomatic heart valvular defects (RVD). METHODS AND MATERIALS: Fifty-six patients treated with sequential chemoradiation therapy for Hodgkin lymphoma (HL) were retrospectively reviewed for RVD events. Clinical information along with whole heart, cardiac chambers, and lung dose distribution parameters was collected, and the correlations to RVD were analyzed by means of Spearman's rank correlation coefficient (Rs). For the selection of the model order and parameters for NTCP modeling, a multivariate logistic regression method using resampling techniques (bootstrapping) was applied. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). RESULTS: When we analyzed the whole heart, a 3-variable NTCP model including the maximum dose, whole heart volume, and lung volume was shown to be the optimal predictive model for RVD (Rs = 0.573, P<.001, AUC = 0.83). When we analyzed the cardiac chambers individually, for the left atrium and for the left ventricle, an NTCP model based on 3 variables including the percentage volume exceeding 30 Gy (V30), cardiac chamber volume, and lung volume was selected as the most predictive model (Rs = 0.539, P<.001, AUC = 0.83; and Rs = 0.557, P<.001, AUC = 0.82, respectively). The NTCP values increase as heart maximum dose or cardiac chambers V30 increase. They also increase with larger volumes of the heart or cardiac chambers and decrease when lung volume is larger. CONCLUSIONS: We propose logistic NTCP models for RVD considering not only heart irradiation dose but also the combined effects of lung and heart volumes. Our study establishes the statistical evidence of the indirect effect of lung size on radio-induced heart toxicity.
PURPOSE: To establish a multivariate normal tissue complication probability (NTCP) model for radiation-induced asymptomatic heart valvular defects (RVD). METHODS AND MATERIALS: Fifty-six patients treated with sequential chemoradiation therapy for Hodgkin lymphoma (HL) were retrospectively reviewed for RVD events. Clinical information along with whole heart, cardiac chambers, and lung dose distribution parameters was collected, and the correlations to RVD were analyzed by means of Spearman's rank correlation coefficient (Rs). For the selection of the model order and parameters for NTCP modeling, a multivariate logistic regression method using resampling techniques (bootstrapping) was applied. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). RESULTS: When we analyzed the whole heart, a 3-variable NTCP model including the maximum dose, whole heart volume, and lung volume was shown to be the optimal predictive model for RVD (Rs = 0.573, P<.001, AUC = 0.83). When we analyzed the cardiac chambers individually, for the left atrium and for the left ventricle, an NTCP model based on 3 variables including the percentage volume exceeding 30 Gy (V30), cardiac chamber volume, and lung volume was selected as the most predictive model (Rs = 0.539, P<.001, AUC = 0.83; and Rs = 0.557, P<.001, AUC = 0.82, respectively). The NTCP values increase as heart maximum dose or cardiac chambers V30 increase. They also increase with larger volumes of the heart or cardiac chambers and decrease when lung volume is larger. CONCLUSIONS: We propose logistic NTCP models for RVD considering not only heart irradiation dose but also the combined effects of lung and heart volumes. Our study establishes the statistical evidence of the indirect effect of lung size on radio-induced heart toxicity.
Authors: Laura Cella; Jung Hun Oh; Joseph O Deasy; Giuseppe Palma; Raffaele Liuzzi; Vittoria D'avino; Manuel Conson; Marco Picardi; Marco Salvatore; Roberto Pacelli Journal: Acta Oncol Date: 2015-03-24 Impact factor: 4.089
Authors: D Alterio; M A Gerardi; L Cella; R Spoto; V Zurlo; A Sabbatini; C Fodor; V D'Avino; M Conson; F Valoriani; D Ciardo; R Pacelli; A Ferrari; P Maisonneuve; L Preda; R Bruschini; M Cossu Rocca; E Rondi; S Colangione; G Palma; S Dicuonzo; R Orecchia; G Sanguineti; B A Jereczek-Fossa Journal: Strahlenther Onkol Date: 2017-09-07 Impact factor: 3.621
Authors: David J Cutter; Michael Schaapveld; Sarah C Darby; Michael Hauptmann; Frederika A van Nimwegen; Augustinus D G Krol; Cecile P M Janus; Flora E van Leeuwen; Berthe M P Aleman Journal: J Natl Cancer Inst Date: 2015-02-23 Impact factor: 13.506
Authors: Laura Cella; Giuseppe Palma; Joseph O Deasy; Jung Hun Oh; Raffaele Liuzzi; Vittoria D'Avino; Manuel Conson; Novella Pugliese; Marco Picardi; Marco Salvatore; Roberto Pacelli Journal: PLoS One Date: 2014-10-31 Impact factor: 3.240
Authors: A Franco; M Ciccarelli; D Sorriento; L Napolitano; A Fiordelisi; B Trimarco; M Durante; G Iaccarino Journal: Transl Med UniSa Date: 2016-05-16
Authors: Y Jessica Huang; Alexis Harrison; Vikren Sarkar; Prema Rassiah-Szegedi; Hui Zhao; Martin Szegedi; Long Huang; Brent Wilson; David K Gaffney; Bill J Salter Journal: Adv Radiat Oncol Date: 2016-04-26
Authors: Michael M Dominello; Matthew D Fountain; Shoshana E Rothstein; Alexa C Cannon; Lisa M Abernathy; David Hoogstra; Wei Chen; Michael C Joiner; Gilda G Hillman Journal: J Radiat Oncol Date: 2017-03-22